Anticancer researchHumansAntibodiesMonoclonalHumanizedRectal Neoplasms
Remarkable and Durable Tumor Response to Pembrolizumab in Locally Advanced dMMR/MSI-H Rectal Cancer.
Ayumu Hosokawa, Rin Yamada, Yukiko Otsuki, Hotaka Tamura, Akiko Ichihara, Tsuyoshi Fukushima, Yoshihiro Komohara
Published: 202510.21873/anticanres.17847
Abstract
BACKGROUND/AIM: Immune checkpoint inhibitors have demonstrated significant clinical efficacy in patients with mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) colorectal cancer. Although current evidence is based on studies wi…
Preview only. Read the full abstract at the source